The purpose of this study is to locate clinical markers (for example, interviews, questionnaires, and computer tasks) and biological markers (for example, physiological, blood-based, or electroencephalography measurements) that predict response to cognitive behavioral therapy for depression.
Forty adult outpatients with major depressive disorder or persistent depressive disorder will receive up to 20 sessions of cognitive behavioral therapy for depression over 16 weeks. Participants will complete clinical measures (interviews, questionnaires, and computer-based tasks) and biological measures (blood tests, physiological measurements, electroencephalography ) before, during, and after treatment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
41
Cognitive Behavioral Therapy will include core mandatory modules of key effective components (e.g., behavioural activation, cognitive restructuring) and optional elements to address individual maintaining factors (e.g., coping and social skills training, perfectionism and self-criticism).
Centre for Addiction and Mental Health
Toronto, Ontario, Canada
Montgomery Asberg Depression Rating Scale
Depression symptom severity
Time frame: 16 weeks
Quick Inventory of Depressive Symptomatology (QIDS)
Depression symptom severity
Time frame: 16 weeks
World Health Organization Quality of Life Short Version (WHOQOL-BREF)
Quality of life
Time frame: 16 weeks
Hamilton Depression Rating Scale (Ham-D)
Depression symptom severity
Time frame: 16 weeks
Beck Depression Inventory (BDI)
Depression symptom severity
Time frame: 16 weeks
Work and Social Adjustment Scale (WSAS)
Functioning and impairment
Time frame: 16 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.